Dalbavancin is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin, the most widely used and one of the few treatments available to patients infected with methicillin-resistant Staphylococcus aureus (MRSA).
The global Dalbavancin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Dabavan star is a new antibiotic developed by Durata, named Dalvance, which was approved by FDA to be marketed in the United States on May 23, 2014. It is used to treat complex acute bacterial skin and skin structure infections in adults.听The drug is a second-generation glycopeptide antibiotic given intravenously.
Report Covers:
This report presents an overview of global market for Dalbavancin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dalbavancin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dalbavancin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dalbavancin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dalbavancin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dalbavancin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbvie
Johnson
Sanofi
Merck
Novartis
Gilead
GSK
Amgen
Hayao
Segment by Type
Intravenous Therapy
Oral Type
Segment by Application
Skin Infection
Soft Tissue Infection
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Dalbavancin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Dalbavancin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dalbavancin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Dalbavancin Product Introduction
1.2 Market by Type
1.2.1 Global Dalbavancin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Intravenous Therapy
1.2.3 Oral Type
1.3 Market by Application
1.3.1 Global Dalbavancin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Skin Infection
1.3.3 Soft Tissue Infection
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dalbavancin Sales Estimates and Forecasts 2019-2030
2.2 Global Dalbavancin Revenue by Region
2.2.1 Global Dalbavancin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Dalbavancin Revenue by Region (2019-2024)
2.2.3 Global Dalbavancin Revenue by Region (2025-2030)
2.2.4 Global Dalbavancin Revenue Market Share by Region (2019-2030)
2.3 Global Dalbavancin Sales Estimates and Forecasts 2019-2030
2.4 Global Dalbavancin Sales by Region
2.4.1 Global Dalbavancin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Dalbavancin Sales by Region (2019-2024)
2.4.3 Global Dalbavancin Sales by Region (2025-2030)
2.4.4 Global Dalbavancin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dalbavancin Sales by Manufacturers
3.1.1 Global Dalbavancin Sales by Manufacturers (2019-2024)
3.1.2 Global Dalbavancin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dalbavancin in 2023
3.2 Global Dalbavancin Revenue by Manufacturers
3.2.1 Global Dalbavancin Revenue by Manufacturers (2019-2024)
3.2.2 Global Dalbavancin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dalbavancin Revenue in 2023
3.3 Global Key Players of Dalbavancin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Dalbavancin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dalbavancin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dalbavancin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dalbavancin, Product Offered and Application
3.8 Global Key Manufacturers of Dalbavancin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dalbavancin Sales by Type
4.1.1 Global Dalbavancin Historical Sales by Type (2019-2024)
4.1.2 Global Dalbavancin Forecasted Sales by Type (2025-2030)
4.1.3 Global Dalbavancin Sales Market Share by Type (2019-2030)
4.2 Global Dalbavancin Revenue by Type
4.2.1 Global Dalbavancin Historical Revenue by Type (2019-2024)
4.2.2 Global Dalbavancin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Dalbavancin Revenue Market Share by Type (2019-2030)
4.3 Global Dalbavancin Price by Type
4.3.1 Global Dalbavancin Price by Type (2019-2024)
4.3.2 Global Dalbavancin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Dalbavancin Sales by Application
5.1.1 Global Dalbavancin Historical Sales by Application (2019-2024)
5.1.2 Global Dalbavancin Forecasted Sales by Application (2025-2030)
5.1.3 Global Dalbavancin Sales Market Share by Application (2019-2030)
5.2 Global Dalbavancin Revenue by Application
5.2.1 Global Dalbavancin Historical Revenue by Application (2019-2024)
5.2.2 Global Dalbavancin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Dalbavancin Revenue Market Share by Application (2019-2030)
5.3 Global Dalbavancin Price by Application
5.3.1 Global Dalbavancin Price by Application (2019-2024)
5.3.2 Global Dalbavancin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Dalbavancin Market Size by Type
6.1.1 US & Canada Dalbavancin Sales by Type (2019-2030)
6.1.2 US & Canada Dalbavancin Revenue by Type (2019-2030)
6.2 US & Canada Dalbavancin Market Size by Application
6.2.1 US & Canada Dalbavancin Sales by Application (2019-2030)
6.2.2 US & Canada Dalbavancin Revenue by Application (2019-2030)
6.3 US & Canada Dalbavancin Market Size by Country
6.3.1 US & Canada Dalbavancin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Dalbavancin Sales by Country (2019-2030)
6.3.3 US & Canada Dalbavancin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dalbavancin Market Size by Type
7.1.1 Europe Dalbavancin Sales by Type (2019-2030)
7.1.2 Europe Dalbavancin Revenue by Type (2019-2030)
7.2 Europe Dalbavancin Market Size by Application
7.2.1 Europe Dalbavancin Sales by Application (2019-2030)
7.2.2 Europe Dalbavancin Revenue by Application (2019-2030)
7.3 Europe Dalbavancin Market Size by Country
7.3.1 Europe Dalbavancin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Dalbavancin Sales by Country (2019-2030)
7.3.3 Europe Dalbavancin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dalbavancin Market Size
8.1.1 China Dalbavancin Sales (2019-2030)
8.1.2 China Dalbavancin Revenue (2019-2030)
8.2 China Dalbavancin Market Size by Application
8.2.1 China Dalbavancin Sales by Application (2019-2030)
8.2.2 China Dalbavancin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Dalbavancin Market Size by Type
9.1.1 Asia Dalbavancin Sales by Type (2019-2030)
9.1.2 Asia Dalbavancin Revenue by Type (2019-2030)
9.2 Asia Dalbavancin Market Size by Application
9.2.1 Asia Dalbavancin Sales by Application (2019-2030)
9.2.2 Asia Dalbavancin Revenue by Application (2019-2030)
9.3 Asia Dalbavancin Sales by Region
9.3.1 Asia Dalbavancin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Dalbavancin Revenue by Region (2019-2030)
9.3.3 Asia Dalbavancin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dalbavancin Market Size by Type
10.1.1 Middle East, Africa and Latin America Dalbavancin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Dalbavancin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Dalbavancin Market Size by Application
10.2.1 Middle East, Africa and Latin America Dalbavancin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Dalbavancin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Dalbavancin Sales by Country
10.3.1 Middle East, Africa and Latin America Dalbavancin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Dalbavancin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Dalbavancin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Roche Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Pfizer Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Abbvie
11.3.1 Abbvie Company Information
11.3.2 Abbvie Overview
11.3.3 Abbvie Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Abbvie Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbvie Recent Developments
11.4 Johnson
11.4.1 Johnson Company Information
11.4.2 Johnson Overview
11.4.3 Johnson Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Johnson Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sanofi Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Overview
11.6.3 Merck Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Merck Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Recent Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Overview
11.7.3 Novartis Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Novartis Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
11.8 Gilead
11.8.1 Gilead Company Information
11.8.2 Gilead Overview
11.8.3 Gilead Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Gilead Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Gilead Recent Developments
11.9 GSK
11.9.1 GSK Company Information
11.9.2 GSK Overview
11.9.3 GSK Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 GSK Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GSK Recent Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Overview
11.10.3 Amgen Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Amgen Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amgen Recent Developments
11.11 Hayao
11.11.1 Hayao Company Information
11.11.2 Hayao Overview
11.11.3 Hayao Dalbavancin Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hayao Dalbavancin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hayao Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dalbavancin Industry Chain Analysis
12.2 Dalbavancin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dalbavancin Production Mode & Process
12.4 Dalbavancin Sales and Marketing
12.4.1 Dalbavancin Sales Channels
12.4.2 Dalbavancin Distributors
12.5 Dalbavancin Customers
13 Market Dynamics
13.1 Dalbavancin Industry Trends
13.2 Dalbavancin Market Drivers
13.3 Dalbavancin Market Challenges
13.4 Dalbavancin Market Restraints
14 Key Findings in The Global Dalbavancin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Roche
Pfizer
Abbvie
Johnson
Sanofi
Merck
Novartis
Gilead
GSK
Amgen
Hayao
听
听
*If Applicable.